Regeneron Study Site is a clinical research site located in Houston, Texas, United States 77004.
Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.
Regeneron Study Site has participated in 33 clinical trials.
Therapeutic areas: Atopic Dermatitis, Neovascular (Wet) Age-Related Macular Degeneration, Relapsed Multiple Myeloma.
Sponsors: Regeneron Pharmaceuticals.
Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Regeneron Study Site has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Regeneron Study Site has 33 clinical trials on record. Their work covers Atopic Dermatitis, Neovascular (Wet) Age-Related Macular Degeneration, Relapsed Multiple Myeloma.
Yes — Regeneron Study Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.